Human papillomavirus
Matsumoto, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 345-349
2010
ISSN/ISBN: 0047-1852 PMID: 20942076 Document Number: 641786
Document emailed within 1 workday
Related Documents
Brown, B.; Blas, M.M.; Heidari, O.; Carcamo, C.; Halsey, N.A. 2013: Reported changes in sexual behaviour and human papillomavirus knowledge in Peruvian female sex workers following participation in a human papillomavirus vaccine trial International Journal of Std and Aids 24(7): 531-535Bond, S.M.; Cartmell, K.B.; Lopez, C.M.; Ford, M.E.; Brandt, H.M.; Gore, E.I.; Zapka, J.G.; Alberg, A.J. 2016: Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females Journal of Pediatric and Adolescent Gynecology 29(5): 429-435
Moscarini, M.; Lukic, A.; Franco, C. 2004: Anti human papillomavirus vaccine: the checkmate to human papillomavirus? European Journal of Gynaecological Oncology 25(2): 151-156
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Su, L.L. 1987: A study on the relationship between human papillomavirus infection and cervical carcinoma development. Immunoperoxidase localization of papillomavirus antigen in cervical tissue Chinese Medical Journal 100(9): 750-752
Shay, J.W.; Wright, W.E.; Brasiskyte, D.; Van der Haegen, B.A. 1993: E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts Oncogene 8(6): 1407-1413
Anwar, K.; Nakakuki, K.; Imai, H.; Shiraishi, T.; Inuzuka, M. 1996: Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma Jpma. Journal of the Pakistan Medical Association 46(10): 220-224
Camargo, M.; Soto-De Leon, S.C.; Munoz, M.; Sanchez, R.; Peña-Herrera, D.; Pineda-Peña, A.C.; Sussmann, O.; Paez, C.; Perez-Prados, A.; Patarroyo, M.E.; Patarroyo, M.A. 2014: Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia Bmc Cancer 14: 451
Joshi, S.; Babu, J.M.; Jayalakshmi, D.; Kulkarni, V.; Divate, U.; Muwonge, R.; Gheit, T.; Tommasino, M.; Sankaranarayanan, R.; Pillai, M.R. 2014: Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India Vaccine 32(9): 1079-1085
Vernon, S.D.; Icenogle, J.P.; Johnson, P.R.; Reeves, W.C. 1992: Human papillomavirus, human immunodeficiency virus, and cervical cancer: newly recognized associations? Infectious Agents and Disease 1(6): 319-324
Mbulawa, Z.Z.A.; Johnson, L.F.; Marais, D.J.; Coetzee, D.; Williamson, A.-L. 2013: The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples Journal of Infection 67(1): 51-58
Reznikoff, C.A.; Yeager, T.R.; Belair, C.D.; Savelieva, E.; Puthenveettil, J.A.; Stadler, W.M. 1996: Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells Cancer Research 56(13): 2886-2890
Kreiss, J.K.; Kiviat, N.B.; Plummer, F.A.; Roberts, P.L.; Waiyaki, P.; Ngugi, E.; Holmes, K.K. 1992: Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes Sexually Transmitted Diseases 19(1): 54-59
Chen, T.M.; Pecoraro, G.; Defendi, V. 1993: Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells Cancer Research 53(5): 1167-1171
Melgaço, F.G.; Rosa, M.L.G.; Augusto, E.F.; Haimuri, J.G.S.; Jacintho, C.; Santos, L.S.; Cavalcanti, S.M.B.; Oliveira, L.H.S. 2011: Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus Archives of Gynecology and Obstetrics 283(4): 809-817
Malik, Z.A.; Hailpern, S.M.; Burk, R.D. 2008: Predictors of seropositivity to human papillomavirus type 53: one of the most prevalent high risk-related cervical human papillomaviruses Viral Immunology 21(3): 371-377
Dames, D.N.; Blackman, E.; Butler, R.; Taioli, E.; Eckstein, S.; Devarajan, K.; Griffith-Bowe, A.; Gomez, P.; Ragin, C. 2014: High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas Plos one 9(1): E85429
Zhang, Y.-x.; Xiong, Y.; Gui, X.-e.; Chen, S.-h.; Rong, Y.-p.; Cai, H.-b. 2011: Epidemiologic risk profile of human papillomavirus infections in human immunodeficiency virus-positive Chinese women Japanese Journal of Infectious Diseases 64(5): 411-416
Woodworth, C.D.; Waggoner, S.; Barnes, W.; Stoler, M.H.; Dipaolo, J.A. 1990: Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo Cancer Research 50(12): 3709-3715
Sirimai, K.; Chalermchockcharoenkit, A.; Roongpisuthipong, A.; Pongprasobchai, S. 2004: Associated risk factors of human papillomavirus cervical infection among human immunodificiency virus-seropositive women at Siriraj Hospital Journal of the Medical Association of Thailand 87(3): 270-276